Cargando…

FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens

Chaperone-usher fimbrial adhesins are powerful weapons against the uropathogens that allow the establishment of urinary tract infections (UTIs). As the antibiotic therapeutic strategy has become less effective in the treatment of uropathogen-related UTIs, the anti-adhesive molecules active against f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarshar, Meysam, Behzadi, Payam, Ambrosi, Cecilia, Zagaglia, Carlo, Palamara, Anna Teresa, Scribano, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400442/ https://www.ncbi.nlm.nih.gov/pubmed/32664222 http://dx.doi.org/10.3390/antibiotics9070397

Ejemplares similares

d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications
por: Scribano, Daniela, et al.
Publicado: (2020)

Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists
por: Mousavifar, Leila, et al.
Publicado: (2023)

Acinetobacter baumannii Targets Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAMs) for Invasion of Pneumocytes
por: Ambrosi, Cecilia, et al.
Publicado: (2020)

Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen
por: Sarshar, Meysam, et al.
Publicado: (2021)

Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran
por: Asadi, Karam MR, et al.
Publicado: (2012)

Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist
por: Spaulding, Caitlin N., et al.
Publicado: (2017)

D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic Escherichia coli
por: Montes-Robledo, Alfredo, et al.
Publicado: (2021)

Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH
por: Mousavifar, Leila, et al.
Publicado: (2019)

Insights into the Periplasmic Proteins of Acinetobacter baumannii AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach
por: Scribano, Daniela, et al.
Publicado: (2019)

A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria
por: Sarshar, Meysam, et al.
Publicado: (2019)

Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli
por: Nasi, Georgia I., et al.
Publicado: (2023)

The FimH Gene in Uropathogenic Escherichia coli Strains Isolated From Patients With Urinary Tract Infection
por: Hojati, Zohreh, et al.
Publicado: (2015)

FimH and Type 1 Pili Mediated Tumor Cell Cytotoxicity by Uropathogenic Escherichia coli In Vitro
por: Van Eyssen, Shelly Roselyn, et al.
Publicado: (2023)

Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates
por: Marazzato, Massimiliano, et al.
Publicado: (2022)

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
por: Behzadi, Payam, et al.
Publicado: (2022)

Transcriptional Response Of E. coli Upon FimH-mediated Fimbrial Adhesion
por: Bhomkar, Prasanna, et al.
Publicado: (2010)

Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
por: Zhang, Wei, et al.
Publicado: (2020)

Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions
por: Sarshar, Meysam, et al.
Publicado: (2020)

The Acinetobacter baumannii model can explain the role of small non-coding RNAs as potential mediators of host-pathogen interactions
por: Sarshar, Meysam, et al.
Publicado: (2022)

Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli
por: Kisiela, Dagmara I., et al.
Publicado: (2015)

Catch-bond mechanism of the bacterial adhesin FimH
por: Sauer, Maximilian M., et al.
Publicado: (2016)

FimH as a scaffold for regulated molecular recognition
por: Ludwig, Shivani Gupta, et al.
Publicado: (2021)

CRISPRi Induced Suppression of Fimbriae Gene (fimH) of a Uropathogenic Escherichia coli: An Approach to Inhibit Microbial Biofilms
por: Zuberi, Azna, et al.
Publicado: (2017)

Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin
por: de Ruyck, Jerome, et al.
Publicado: (2016)

En route to photoaffinity labeling of the bacterial lectin FimH
por: Lindhorst, Thisbe K, et al.
Publicado: (2010)

Diazirine-functionalized mannosides for photoaffinity labeling: trouble with FimH
por: Beiroth, Femke, et al.
Publicado: (2018)

Editorial: Uropathogens, urinary tract infections, the host-pathogen interactions and treatment
por: Behzadi, Payam, et al.
Publicado: (2023)

Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way
por: Pompilio, Arianna, et al.
Publicado: (2021)

Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations
por: Feenstra, T., et al.
Publicado: (2016)

Selection for nonspecific adhesion is a driver of FimH evolution increasing Escherichia coli biofilm capacity
por: Yoshida, Mari, et al.
Publicado: (2022)

FimH-based display of functional eukaryotic proteins on bacteria surfaces
por: Chmielewski, Markus, et al.
Publicado: (2019)

Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation—The Example of FimH
por: Krammer, Eva-Maria, et al.
Publicado: (2018)

Are D-manno-configured Amadori products ligands of the bacterial lectin FimH?
por: Gloe, Tobias-Elias, et al.
Publicado: (2015)

A Novel Integrated Way for Deciphering the Glycan Code for the FimH Lectin
por: Dumych, Tetiana, et al.
Publicado: (2018)

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease
por: Chevalier, Grégoire, et al.
Publicado: (2021)

In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infections
por: Habibi, Mehri, et al.
Publicado: (2015)

Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex
por: Wellens, Adinda, et al.
Publicado: (2008)

Inflammatory Response in Caco-2 Cells Stimulated with Anisakis Messengers of Pathogenicity
por: Bellini, Ilaria, et al.
Publicado: (2022)

Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
por: Mashraqi, Mutaib M., et al.
Publicado: (2021)

A bivalent glycopeptide to target two putative carbohydrate binding sites on FimH
por: Lindhorst, Thisbe K, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q8pp3s094nuhuolq5ugjputrgc